Laboratoires Euromedis Société anonyme (EPA:ALEMG)
France · Delayed Price · Currency is EUR 5.10
-0.15 (-2.86%)
Sep 4, 2026, 4:38 PM CET
EPA:ALEMG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15 | 11 | 13 | 16 | 14 | 31 | |
Market Cap Growth | 21.33% | -11.06% | -19.36% | 8.08% | -54.01% | -16.91% |
Enterprise Value | 4 | 3 | 3 | 5 | -2 | 31 |
Last Close Price | 5.10 | 3.92 | 4.40 | 5.32 | 4.81 | 10.50 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 1.19 | - | 13.86 |
Forward PE | - | 9.14 | 10.63 | 16.12 | 2.77 | 4.66 |
PS Ratio | 0.35 | 0.27 | 0.34 | 0.46 | 0.27 | 0.28 |
PB Ratio | 0.89 | 0.68 | 0.76 | 0.69 | 0.41 | 0.76 |
P/TBV Ratio | 0.90 | 0.69 | 0.76 | 0.69 | 0.45 | 0.82 |
P/FCF Ratio | - | - | - | - | - | 1.80 |
P/OCF Ratio | - | - | - | - | - | 1.63 |
PEG Ratio | - | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.10 | 0.08 | 0.08 | 0.15 | - | 0.28 |
EV/EBITDA Ratio | 7.49 | 6.47 | 4.07 | - | - | 5.98 |
EV/EBIT Ratio | 12.72 | 10.99 | 6.05 | - | - | 7.41 |
EV/FCF Ratio | - | - | - | - | - | 1.78 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.37 | 0.37 | 0.49 | 0.44 | 0.37 | 0.38 |
Debt / EBITDA Ratio | 11.44 | 11.44 | 11.89 | - | - | 2.99 |
Debt / FCF Ratio | - | - | - | - | - | 0.89 |
Net Debt / Equity Ratio | -0.64 | -0.64 | -0.43 | 0.44 | -0.40 | -0.40 |
Net Debt / EBITDA Ratio | -19.80 | -19.80 | -10.57 | -2.26 | 3.48 | -3.14 |
Net Debt / FCF Ratio | - | - | - | - | 6.71 | -0.94 |
Asset Turnover | 1.05 | 1.05 | 0.86 | 0.64 | 0.82 | 1.35 |
Inventory Turnover | 2.97 | 2.97 | 2.79 | 2.89 | 2.91 | 4.18 |
Quick Ratio | 2.22 | 2.22 | 2.23 | 1.08 | 4.00 | 3.80 |
Current Ratio | 3.09 | 3.09 | 3.53 | 4.41 | 5.47 | 4.80 |
Return on Equity (ROE) | -0.80% | -0.80% | -31.26% | 45.62% | -15.61% | 5.75% |
Return on Assets (ROA) | 0.50% | 0.50% | 0.67% | -6.54% | -4.84% | 3.17% |
Return on Invested Capital (ROIC) | -1.29% | -0.99% | 2.16% | -20.35% | -22.41% | 11.67% |
Return on Capital Employed (ROCE) | 1.20% | 1.20% | 1.60% | -14.90% | -10.20% | 7.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.90% | -1.18% | -48.73% | 84.34% | -41.25% | 7.21% |
FCF Yield | -35.52% | - | - | - | -14.46% | 55.67% |
Buyback Yield / Dilution | -0.39% | -0.39% | 0.17% | 2.55% | 18.41% | -0.06% |
Total Shareholder Return | -0.39% | -0.39% | 0.17% | 2.55% | 18.41% | -0.06% |